Navigation Links
Smoking Before, After Pregnancy Harms Daughters' Fertility
Date:11/21/2007

it smoking? Visit the U.S. Surgeon General or the National Institutes of Health.



SOURCES: Norman H. Edelman, M.D., consultant, scientific affairs, American Lung Association; Andrea Jurisicova, M.D., assistant professor, University of Toronto, and Canada Research Chair, Molecular and Reproductive Medicine, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto; Amos Grunebaum, M.D., director, obstetrics, New York Weill Cornell Medical Center, New York City; Dec. 3, 2007, Journal of Clinical Investigation


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved  

5

GOOD

Page: 1 2 3 4

Related medicine news :

1. Smoking may strongly increase long-term risk of eye disease
2. Smoking increases risks for head and neck cancers for men and women
3. Smoking Boosts Risk for Head, Neck Cancers
4. AUDIO from Medialink and Commit Lozenge: Wanna Quit Smoking With Therapeutic Nicotine? Just Follow the Directions
5. Passive smoking increases sleep disturbance among pregnant women
6. Teens who see more smoking in movies may have increased risk of becoming established smokers
7. Smoking in Movies May Put Teens at Risk
8. Test Spots Genetic Damage Done by Smoking
9. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
10. Muslim Groups Kick Off Ramadan With Anti-Smoking Initiative
11. Smoking can harm the long-term effects of some oral surgery procedures
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Smoking Before, After Pregnancy Harms Daughters' Fertility
Smoking Before, After Pregnancy Harms Daughters' Fertility
Other Medicine News:Health News:Cord Blood America Reports First Quarter Financial Results; Gross Profits Increase 2Health News:National Ad Campaign Highlights Patient Ratings For More Than 1,000 Local U.S. Hospitals 2Health News:National Ad Campaign Highlights Patient Ratings For More Than 1,000 Local U.S. Hospitals 3Health News:The Children's Hospital of Philadelphia Opens the World's First Delivery Unit for Mothers Diagnosed with Birth Defects in Fetus 2Health News:The Children's Hospital of Philadelphia Opens the World's First Delivery Unit for Mothers Diagnosed with Birth Defects in Fetus 3Health News:The Children's Hospital of Philadelphia Opens the World's First Delivery Unit for Mothers Diagnosed with Birth Defects in Fetus 4Health News:Mayo Clinic Research Shows U.S. Intensive Care Units' Prevention of Pneumonia in Critically-ill Patients Generally Strong; Identifies Area of Improvement 2Health News:Mayo Clinic Research Shows U.S. Intensive Care Units' Prevention of Pneumonia in Critically-ill Patients Generally Strong; Identifies Area of Improvement 3Health News:Concomitant use of Perforomist & tiotropium -- significant improvements -- COPD 2Health News:Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD 2Health News:Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD 3Health News:Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD 4
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 1VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 2VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 3VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 4VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 5Jubilant to Work With Endo Pharmaceuticals on Drug Development 12582 1Jubilant to Work With Endo Pharmaceuticals on Drug Development 12582 2Jubilant to Work With Endo Pharmaceuticals on Drug Development 12582 3XELR8 Holdings Inc Hires Vice President of Strategy and Network Development 48585 1XELR8 Holdings Inc Hires Vice President of Strategy and Network Development 48585 2XELR8 Holdings Inc Hires Vice President of Strategy and Network Development 48585 3
Other Medicine Technology:Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 2Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 3Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 4Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 5Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 6Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 7New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 2New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 3New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 4New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 5New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 6New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 7